The American Journal of Nephrology, published by KARGER, stands as a prestigious platform for the dissemination of high-quality research in the field of nephrology, boasting an impressive Q1 ranking in its category as of 2023. With its ISSN 0250-8095 and E-ISSN 1421-9670, the journal has been committed to advancing knowledge in kidney diseases since its inception in 1981. It serves as an essential resource for researchers, clinicians, and students alike, featuring original articles, reviews, and case reports that contribute to the understanding and treatment of renal conditions. Despite not being an open-access journal, the American Journal of Nephrology ensures a rigorous peer-review process to maintain its high academic standards, making it a vital source of information for the nephrology community worldwide. By providing insights into emerging trends and breakthroughs in kidney health, the journal continues to play a crucial role in shaping the future of nephrology research.

Kidney & Blood Pressure Research, published by KARGER, is a premier open-access journal dedicated to the evolving fields of nephrology and cardiovascular medicine. Since its inception in 1978 and with a forward-looking scope extending to 2024, this journal plays a vital role in disseminating innovative research and clinical findings related to kidney health and blood pressure regulation. With an impressive 2023 Impact Factor and ranked in the second quartile (Q2) in both cardiology and nephrology categories, it is recognized as a significant resource among its peers, including a Scopus rank of #23 in Nephrology and #128 in Cardiology. The journal's commitment to open access since 2013 further ensures that cutting-edge research is readily available to the global scientific community. Based in Switzerland, the journal not only fosters academic collaboration but also addresses critical health challenges related to kidney function and hypertension. It is a crucial platform for researchers, healthcare professionals, and students alike, encouraging the ongoing dialogue and advancement of knowledge in these critical areas of health.

NEPHROLOGY is a leading academic journal published by Wiley, dedicated to advancing research and discussions in the fields of Nephrology and Medicine. With an ISSN of 1320-5358, this journal has consistently demonstrated its significance and impact, reflecting a Q2 category ranking in both Medicine (miscellaneous) and Nephrology as of 2023. Covering a comprehensive range of topics since its inception in 1995, NEPHROLOGY provides a vital platform for researchers, practitioners, and students alike to explore the latest advancements, innovative treatments, and diverse challenges within the field. Although it does not operate under an open access model, the journal remains highly regarded, with a commendable Scopus rank of #27 out of 81 in Nephrology, positioning it in the 67th percentile among its peers. Located in the United Kingdom, NEPHROLOGY invites submissions that push the boundaries of knowledge, ultimately striving to enhance the understanding of renal health and disease.

NEPHROLOGY DIALYSIS TRANSPLANTATION is a premier academic journal published by Oxford University Press that plays a vital role in disseminating cutting-edge research within the fields of nephrology and transplantation. With an impressive impact factor and recognition as Q1 in both these categories for 2023, the journal ranks among the top publications in medicine, enhancing its visibility among a global audience of researchers, healthcare professionals, and students. Established in 1986, the journal has maintained a commitment to publishing high-quality, peer-reviewed articles that contribute to the advancement of knowledge and practice in renal medicine. Although this journal does not offer open access options, it remains a highly regarded resource due to its rigorous selection process and influential contributions to the field. Scholars are encouraged to explore the journal’s extensive archive, spanning from 1986 to 2024, for invaluable insights and developments in nephrology and transplantation.

Kidney International Reports, published by ELSEVIER SCIENCE INC, stands as a premier open-access journal in the realm of nephrology, having established itself since its inception in 2016. This scholarly platform, with an ISSN of 2468-0249, is dedicated to presenting high-quality research and critical reviews that advance our understanding of kidney health and disease. With a remarkable Q1 ranking in nephrology and a notable position within the top 10 of Scopus rankings for this specialty, the journal is a pivotal resource for researchers, healthcare professionals, and students alike. Featuring a broad scope of topics from clinical nephrology to innovative treatment strategies, Kidney International Reports ensures accessibility to the latest findings through its open access model, making it instrumental in promoting knowledge sharing and collaboration across the global nephrology community. The journal's commitment to excellence not only enhances the visibility of research but also fosters the development of effective treatments and therapies for kidney diseases.

Kidney360 (ISSN: 2641-7650) is a prominent open-access journal published by the American Society of Nephrology, dedicated to advancing the field of nephrology and its intersecting medical disciplines. Established with a vision to foster innovative research and promote a deeper understanding of kidney health, this journal is positioned as a vital resource for nephrologists, researchers, and healthcare professionals. With its classification in Q1 in Nephrology and Q2 in Medicine (miscellaneous) for 2023, Kidney360 ranks favorably, highlighting its commitment to publish high-quality, impactful research, recognized in the top percentile of its field. The journal's accessible platform aims to disseminate knowledge effectively, making it an essential repository for cutting-edge studies, reviews, and clinical research. By encouraging collaboration across various disciplines, Kidney360 plays a critical role in shaping the future of nephrology and enhancing patient care on a global scale.

Kidney International Supplements is a prestigious academic journal published by Elsevier Science Inc, specializing in the field of nephrology. With an impressive impact factor and ranked in the top percentile, it holds the esteemed position of Q1 in nephrology categories, reflecting its influential contribution to the academic community. Throughout its publication history from 2011 to 2022 and in the anticipated 2024 edition, the journal has provided a vital platform for disseminating high-quality research and insights, catering to professionals, researchers, and students dedicated to advancing kidney health. While it offers traditional access options, the journal is committed to promoting the highest standards of research integrity and innovation in nephrology. The journal plays an essential role in shaping the future of kidney disease treatment, levelling knowledge exchange across specialties, and fostering collaboration among experts in the field.

SEMINARS IN DIALYSIS is a reputable peer-reviewed journal published by WILEY, focusing on advancements in the field of nephrology, particularly in the context of dialysis. With its ISSN 0894-0959 and E-ISSN 1525-139X, this journal serves as an essential resource for researchers, healthcare professionals, and students committed to exploring innovative practices and solutions in kidney health. Since its inception in 1988 and continuing to 2024, the journal has established itself in the Q2 category of nephrology, highlighting its significance in academic discourse, as reflected by its Scopus rank of #42 out of 81 in the field. Although not openly accessible, SEMINARS IN DIALYSIS offers crucial insights into clinical practices and research findings that shape the future of dialysis treatment, making it a cornerstone publication for those dedicated to improving patient outcomes in nephrology.

INTERNATIONAL UROLOGY AND NEPHROLOGY, published by SPRINGER, stands as a premier journal in the fields of urology and nephrology, boasting a commendable impact factor as reflected in its Q2 category rankings in both domains as of 2023. Since its inception in 1970, the journal has dedicated itself to disseminating cutting-edge research and clinical advancements that significantly impact the practice and understanding of urology and nephrology. With a Scopus rank placing it in the upper percentiles—46th out of 120 in urology and 38th out of 81 in nephrology—it offers a vital platform for researchers, healthcare professionals, and students alike to engage with high-quality, peer-reviewed articles. Although it does not operate as an open access journal, the wealth of knowledge contained within its pages remains indispensable for those committed to advancing the medical fields of urology and nephrology. The journal is located in Dordrecht, Netherlands, emphasizing its commitment to global research collaboration.

CLINICAL NEPHROLOGY is a prestigious academic journal dedicated to advancing the field of nephrology and related areas of medicine. Published by DUSTRI-VERLAG DR KARL FEISTLE, this journal has been a critical resource for researchers and practitioners since its inception in 1973, with a commitment to disseminating high-quality, peer-reviewed articles that provide insights into clinical practices, innovative treatments, and emerging research in kidney diseases. With an ISSN of 0301-0430, CLINICAL NEPHROLOGY stands out in the medical community, achieving a commendable Q3 ranking in both general medicine and nephrology fields as of 2023. The journal's focus on both clinical application and rigorous scientific inquiry makes it an essential read for healthcare professionals and researchers looking to stay at the forefront of nephrology advancements. Although it operates under a subscription model, its broad scope promises invaluable contributions that address practical challenges and foster interdisciplinary dialogue within the healthcare landscape.